Clinical Trials Directory

Trials / Completed

CompletedNCT01176253

Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Reaction (PCR)

Detection of Human Beta Cell Death in T1DM by Methylation Specific PCR

Status
Completed
Phase
Study type
Observational
Enrollment
6 (actual)
Sponsor
City of Hope Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To investigate the use of methylation-specific PCR (MSP) assays to detect human beta cell-specific gene methylation patterns in serial blood samples drawn from newly diagnosed Type 1 diabetics.

Detailed description

The study will follow 25 newly diagnosed type 1 diabetic patients from the onset of symptoms to one year post-diagnosis. A total of 11 fasting blood draws will be taken, the first near the time of diabetes diagnosis, then 2 weeks later, monthly for the next 6 months, and every other month until 12 months. Each blood sample will be evaluated by the MSP assay, as well as for measurement of fasting plasma glucose, HbA1c, c-peptide, and autoantibodies. The study will also need 25 healthy volunteers to help us match some DNA markers needed for this data. Healthy volunteers will be se=matched healthy individuals who have one blood sample drawn.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood drawBlood draw for Type I DM patients will be taken every 4 weeks for 1 year post diagnosis/healthy volunteers will have 1 blood draw

Timeline

Start date
2009-07-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2010-08-05
Last updated
2015-05-01

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01176253. Inclusion in this directory is not an endorsement.